| Date | Title | Description | Source |
| 24.04.2024 | Govt expands committee for drugs, medical devices pricing re... | - | business-s... |
| 15.04.2024 | Women of Influence: Health Care 2024 – Ileana Hernandez | - | labusiness... |
| 09.04.2024 | Clinical success for Neurimmune |
Transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed, systemic clinical con... | startuptic... |
| 25.03.2024 | Ultomiris approved in the US for NMOSD | Ultomiris approved in the US for NMOSD
Mon, Mar 25, 2024 08:00 CET Report this content
25 March 2024... | news.cisio... |
| 18.03.2024 | AstraZeneca купит Amolyt Pharma за $1,05 млрд | По условиям сделки AstraZeneca купит Amolyt Pharma за общую сумму до $1,05 млрд без учета денежных с... | inventure.... |
| 18.03.2024 | AstraZeneca to acquire Amolyt Pharma, expanding late-stage r... | Amolyt development portfolio includes Phase III asset with potential to address significant unmet ne... | cambridgen... |
| 14.03.2024 | AstraZeneca Acquisition Brings Drug to Fill a Rare Disease G... | AstraZeneca is bolstering its rare disease pipeline with a deal to buy Amolyt Pharma, a biotech comp... | medcitynew... |
| 14.03.2024 | Rare Disease Advocates Learn to Accelerate Therapeutic Devel... | RARE Drug Development Symposium
The RARE Drug Development Symposium, hosted by Global Genes and the ... | prweb.com/... |
| 14.03.2024 | Amolyt Pharma, an Andera Partners’ portfolio company, announ... | Amolyt Pharma, a global, clinical-stage biopharmaceutical company specializing in developing therape... | anderapart... |
| 29.02.2024 | Often misdiagnosed, it's time to raise awareness of the rare... | (BPT) - What started as a dream trip to Hawaii became a medical turning point for Sally Cox. While s... | salamancap... |
| 07.01.2022 | Neurimmune and AstraZeneca join forces | | startuptic... |
| 20.09.2021 | Genomenon Announces Collaboration to Accelerate Genetic Diag... | “We are encouraged by our collaboration with Genomenon and the potential to advance our collective e... | prweb.com/... |
| 15.07.2021 | Alexion Pharmaceuticals : AstraZeneca receives final regulat... | The UK Competition and Markets Authority has cleared AstraZeneca's proposed acquisition of Alexion P... | marketscre... |
| 14.07.2021 | AstraZeneca : receives final regulatory clearance for the pr... | PUBLISHED14 July 2021
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR... | marketscre... |
| 14.07.2021 | AstraZeneca : receives final regulatory clearance for the pr... | AstraZeneca receives final regulatory clearance for the proposed acquisition of Alexion from the UK'... | marketscre... |
| 14.07.2021 | AstraZeneca-Alexion transaction cleared in the UK | AstraZeneca-Alexion transaction cleared in the UK Wed, Jul 14, 2021 08:14 CET
NOT FOR RELEASE, PUBLI... | news.cisio... |
| 07.07.2021 | Alexion Pharmaceuticals : AstraZeneca receives clearance fro... | AstraZeneca's proposed acquisition of Alexion Pharmaceuticals, Inc. (Alexion) has achieved an import... | marketscre... |
| 06.07.2021 | AstraZeneca : receives clearance from the European Commissio... | AstraZeneca receives clearance from the European Commission for the proposed acquisition of Alexion
... | marketscre... |
| 07.06.2021 | ALEXION PHARMACEUTICALS, INC.
Alexion Pharmaceuticals : Ale... | Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the U.S. Food and Drug Administration (F... | marketscre... |
| 07.06.2021 | Alexion Pharmaceuticals : Alexion Announces FDA Approval of ... | Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the U.S. Food and Drug Administration (F... | marketscre... |
| 04.06.2021 | AstraZeneca appoints new Chief Financial Officer | AstraZeneca appoints new Chief Financial Officer Fri, Jun 04, 2021 08:00 CET
4 June 2021 07:00 BST
N... | news.cisio... |
| 04.05.2021 | ALEXION PHARMACEUTICALS, INC. : Other Events (form 8-K) | Item 8.01 Other Events.
As previously disclosed, on December 12, 2020, Alexion Pharmaceuticals, Inc.... | marketscre... |
| 19.04.2021 | ALEXION PHARMACEUTICALS, INC.
Alexion Pharmaceuticals : Ast... | AstraZeneca's proposed acquisition of Alexion Pharmaceuticals, Inc (Alexion) has achieved an importa... | marketscre... |
| 16.03.2021 | FTC pledges to aggressively crack down on pharma merger... | The Federal Trade Commission said Tuesday that it’s setting up an international working g... | endpts.com... |
| 04.02.2021 | Alexion Pharmaceuticals : Reports Fourth Quarter and Full Ye... | Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced financial results for the fourth quarter... | marketscre... |
| 14.01.2021 | Covid-19 roundup: Alexion's C5 inhibitor Ultomiris misse... | C5 inhibition isn’t the answer to the search for treatments for severe Covid-19 after all.
Al... | endpts.com... |
| 12.12.2020 | AstraZeneca To Pay $39 Billion For Alexion — 14% Off Its All... | TORONTO, ON - DECEMBER 2 - Toni Vernon poses at her Toronto home, December 2, 2014. Vernon has a ...... | forbes.com... |
| 03.11.2020 | Meet the CXO – George Llado | George Llado – SVP & CIO, Alexion Pharmaceuticals
We had the opportunity to catch up with George... | sierravent... |
| 12.10.2020 | ALEXION PHARMACEUTICALS, INC.
Alexion Pharmaceuticals : Rec... | Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced the U.S. Food and Drug Administration (F... | marketscre... |
| 25.09.2020 | ALEXION PHARMACEUTICALS, INC.
Alexion Pharmaceuticals : ULT... | Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that Japan’s Ministry of Health, Labour ... | marketscre... |
| 01.08.2020 | ALEXION PHARMACEUTICALS, INC.
Alexion Pharmaceuticals : Q2 ... | Second Quarter
2020
Earnings Call
July 30, 2020
BUNNY WITH HER HUSBAND, JOE LIVING WITH PNH
F O R W ... | marketscre... |
| 20.04.2020 | Alexion to start Phase III study of blood disorder drug in C... | Ultomiris is a C5 complement inhibitor approved for treating paroxysmal nocturnal hemoglobinuria. It... | medcitynew... |
| 01.04.2020 | Coronavirus Business Tracker: How The Private Sector Is Figh... | Alain Mérieux, founder of BioMérieux.AFP via Getty Images | forbes.com... |
| 28.01.2019 | After securing quick OK for PNH patients, Alexion's Ul... | About a month after the FDA gave Alexion a Christmas present in the form of an early approval f... | endpts.com... |
| 27.09.2018 | Alexion To Acquire Syntimmune, for Up To $1.2 Billion | Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), a a global biopharmaceutical company, is to acquire Syn... | finsmes.co... |
| 21.08.2018 | FDA accepts Alexion’s application for next-generation PNH dr... | ALXN1210 is a long-acting medicine with the same target as Soliris (eculizumab), for which Alexion w... | medcitynew... |
| 21.12.2016 | More bad news for Alexion: Soliris trial fails | Rumors of possible fraud have been circulating since Alexion missed the deadline for its third quart... | medcitynew... |
| 08.06.2016 | Cloud Therapy Uses Watson to Help Doctors, Pharma With Diagn... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
San Antonio — Andre Sandoval was bo... | xconomy.co... |
| 03.12.2015 | True North, Following the Alexion Rare Disease Playbook, Nab... | Alexion Pharmaceuticals became successful by developing treatments for ultra-rare diseases, the kind... | forbes.com... |
| - | FDA accepts Alexion’s application for next-generation PNH dr... | The Food and Drug Administration has accepted for priority review Alexion Pharmaceuticals’ new drug ... | medcitynew... |
| - | Alexion to start Phase III study of blood disorder drug in C... | A biotech company that markets drugs for rare blood disorders plans to bring its most recently appro... | medcitynew... |
| - | More bad news for Alexion: Soliris trial fails | Alexion Pharmaceuticals quietly reported late Wednesday that its Phase 2/3 trial of eculizumab (Soli... | medcitynew... |
| - | The Orphan Drug Act at 40: still critical for the treatment ... | A champion for equity in research and treatment access, Alexion Vice President for Corporate Affairs... | statnews.c... |
| - | Pioneering a more equitable future for rare disease communit... | In the United States, a rare disease is defined as a disease that affects fewer than 200,000 people.... | statnews.c... |
| - | Is evolving research in complement inhibition a key to findi... | An uncharted pathway
Some of the greatest advancements in modern medicine started with a scientist t... | statnews.c... |
